BONE DENSITY DECREASED

Adverse reaction reported in 50,101 FDA reports across 13 drugs.

50,101
Total Reports
13
Drugs Involved
Emtricitabine / Tenofovir Disoproxil Fumarate
Most Reported Drug

Drugs Associated with BONE DENSITY DECREASED

Drugs where "BONE DENSITY DECREASED" was reported as an adverse event.

# Drug Reports % of Total
1 Emtricitabine / Tenofovir Disoproxil Fumarate 16,540
33.0%
2 Tenofovir Disoproxil 10,655
21.3%
3 Bictegravir Sodium, Emtricitabine, / Tenofovir Alafenamide Fumarate 6,570
13.1%
4 Emtricitabine / Tenofovir Alafenamide 4,815
9.6%
5 Elvitegravir, Cobicistat, Emtricitabine, / Tenofovir Disoproxil Fumarate 4,571
9.1%
6 Elvitegravir, Cobicistat, Emtricitabine, / Tenofovir Alafenamide 4,509
9.0%
7 Ritonavir 572
1.1%
8 Raloxifene 454
0.9%
9 Dolutegravir 400
0.8%
10 Lopinavir / Ritonavir 335
0.7%
11 Darunavir 323
0.6%
12 Lamivudine / Zidovudine 195
0.4%
13 Romosozumab-Aqqg 162
0.3%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused bone density decreased. Always consult your healthcare provider.